人工智能用于数字乳腺断层合成:对诊断性能、阅读时间和工作量的影响
本文综述了人工智能应用于数字乳腺断层合成(DBT)的研究进展,指出AI可提高诊断性能、降低召回率(降幅2%至27%)并缩短阅读时间(最多降低53%,平均降低20%),但AI能否降低间期癌率尚不明确。在个体化筛查时代,需前瞻性验证AI辅助DBT解读的成本效益和真实世界影响,尤其在大规模低患病率研究中。
要点
- AI可降低DBT筛查的召回率和阅读时间,但降低间期癌率的作用未明。
- AI辅助DBT解读需前瞻性验证,尤其在大规模低患病率人群中。
- 个体化筛查中,AI或可缩小非致密乳腺人群DM与DBT的诊断差距。
核心结论
- AI应用于DBT可提高诊断性能、降低召回率(-2%至-27%)和阅读时间(最多-53%,平均-20%),但降低间期癌率的能力尚未明确研究。
- 需前瞻性验证AI辅助DBT解读的成本效益和真实世界影响,尤其在大规模低乳腺癌患病率研究中。
- 在个体化风险分层筛查时代,若AI应用于DM能缩小非致密乳腺人群DM与DBT的诊断性能差距,则可能削弱AI应用于DBT的价值。
研究设计与样本
- 本文为综述,总结了从计算机辅助检测/诊断系统到AI应用于数字乳腺摄影(DM)的发展历程,并汇总了AI应用于DBT的研究结果。
诊断标准与关键数值
- AI应用于DBT可使召回率降低2%至27%,阅读时间最多降低53%(平均降低20%)。
- DBT相对于DM的诊断优势集中于乳腺极度致密女性。
临床应用与阅片要点
- AI辅助DBT解读有望提高筛查诊断性能并减少召回和阅读时间,但降低间期癌率的作用未证实。
- 在个体化筛查中,对非致密乳腺女性可考虑AI辅助DM以缩小与DBT的诊断差距。
局限性
- AI降低间期癌率的能力尚未明确研究。
- 需前瞻性验证AI辅助DBT解读的成本效益和真实世界影响,尤其在大规模低患病率研究中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The ultimate goals of the application of artificial intelligence (AI) to digital breast tomosynthesis (DBT) are the reduction of reading times, the increase of diagnostic performance, and the reduction of interval cancer rates. In this review, after outlining the journey from computer-aided detection/diagnosis systems to AI applied to digital mammography (DM), we summarize the results of studies where AI was applied to DBT, noting that long-term advantages of DBT screening and its crucial ability to decrease the interval cancer rate are still under scrutiny. AI has shown the capability to overcome some shortcomings of DBT in the screening setting by improving diagnostic performance and by reducing recall rates (from -2 % to -27 %) and reading times (up to -53 %, with an average 20 % reduction), but the ability of AI to reduce interval cancer rates has not yet been clearly investigated. Prospective validation is needed to assess the cost-effectiveness and real-world impact of AI models assisting DBT interpretation, especially in large-scale studies with low breast cancer prevalence. Finally, we focus on the incoming era of personalized and risk-stratified screening that will first see the application of contrast-enhanced breast imaging to screen women with extremely dense breasts. As the diagnostic advantage of DBT over DM was concentrated in this category, we try to understand if the application of AI to DM in the remaining cohorts of women with heterogeneously dense or non-dense breast could close the gap in diagnostic performance between DM and DBT, thus neutralizing the usefulness of AI application to DBT.
引用
- Magni, Cozzi, Schiaffino, et al. Artificial intelligence for digital breast tomosynthesis: Impact on diagnostic performance, reading times, and workload in the era of personalized screening. Eur J Radiol. 2022. PMID: 36481480. doi:10.1016/j.ejrad.2022.110631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。